Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies

The incidence of esophageal adenocarcinoma (EAC) has rapidly increased, particularly in the Western world. Despite improvements in perioperative treatments, the overall survival of patients remains low. Claudin 18.2 is a tight junction protein that is exclusively expressed in the gastric epithelia....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: Moentenich, Valeska, Gebauer, Florian, Comut, Erdem, Tuchscherer, Armin, Bruns, Christiane, Schroeder, Wolfgang, Buettner, Reinhard, Alakus, Hakan, Loeser, Heike, Zander, Thomas, Quaas, Alexander
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2020
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204493/
https://ncbi.nlm.nih.gov/pubmed/32391091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11520
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares